Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

Clinical trial NCT01578850 · COMPLETED

Trial details

NCT number

NCT01578850

Sponsor

Pfizer

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2012-07-01

Primary completion

2015-03-01

Enrollment

491

View on ClinicalTrials.gov